Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
309M
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
206M
-
Shares change
-
+4.92M
-
Total reported value, excl. options
-
$2.96B
-
Value change
-
+$69.1M
-
Put/Call ratio
-
0.92
-
Number of buys
-
97
-
Number of sells
-
-80
-
Price
-
$14.39
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2017
245 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q4 2017.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 206M shares
of 309M outstanding shares and own 66.66% of the company stock.
Largest 10 shareholders include FMR LLC (18M shares), PERCEPTIVE ADVISORS LLC (17.9M shares), BlackRock Inc. (13.7M shares), Vanguard Group Inc (13.6M shares), Redmile Group, LLC (10M shares), JENNISON ASSOCIATES LLC (9.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.06M shares), JANUS HENDERSON GROUP PLC (7.92M shares), STATE STREET CORP (7.84M shares), and venBio Select Advisor LLC (7.26M shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.